1. Home
  2. SHBI vs DRUG Comparison

SHBI vs DRUG Comparison

Compare SHBI & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$22.96

Market Cap

758.9M

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$49.32

Market Cap

778.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHBI
DRUG
Founded
1876
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
758.9M
778.4M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SHBI
DRUG
Price
$22.96
$49.32
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$25.60
★ $151.95
AVG Volume (30 Days)
★ 165.4K
75.2K
Earning Date
10-22-2026
08-17-2026
Dividend Yield
★ 2.45%
N/A
EPS Growth
★ 34.85
N/A
EPS
★ 1.07
N/A
Revenue
★ $20,853,000.00
N/A
Revenue This Year
$8.92
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$21.34
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$14.93
$48.53
52 Week High
$24.89
$123.75

Technical Indicators

Market Signals
Indicator
SHBI
DRUG
Relative Strength Index (RSI) 49.22 23.01
Support Level $22.47 N/A
Resistance Level $23.12 $78.35
Average True Range (ATR) 0.42 2.91
MACD -0.01 -0.49
Stochastic Oscillator 64.78 3.09

Price Performance

Historical Comparison
SHBI
DRUG

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: